Head-to-head · Cost-Efficiency Index
WeightRx vs Harper Meds
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
WeightRx
Cost-first shoppers who want the lowest published tirzepatide figure, if you are willing to complete intake before you can read the plan terms.
Visit WeightRxHarper Meds
Cost-first shoppers who want a genuinely all-in flat price with a disclosed operating entity and physician networks.
Visit Harper MedsThe verdict
WeightRx takes it, leading the Cost-Efficiency Index 69 to 68. WeightRx is a telehealth provider publishing compounded semaglutide at $250/mo and compounded tirzepatide at $83/mo. Harper Meds still earns a C — Cost-first shoppers who want a genuinely all-in flat price with a disclosed operating entity and physician networks.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs WeightRx.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | WeightRx | Harper Meds |
|---|---|---|
| Cost-Efficiency Index | 69/100 | 68/100 |
| Semaglutide / mo | $250/mo (compounded) | $149/mo |
| Tirzepatide / mo | $83/mo (term not published, compounded) | $196/mo |
| Semaglutide / yr (modeled) | $3,000 | $1,788 |
| Tirzepatide / yr (modeled) | $996 | $2,352 |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #109 | #113 |
WeightRx
69/100Where the value is
- The tirzepatide figure is published up front, and it is genuinely low against the field
- Both molecules are offered
- No membership charge is advertised alongside the medication rate
The tradeoffs
- The $83 monthly rate is advertised as '$83/month ($997/year)', which is twelve months of it — no month-to-month rate is separately published, and the terms state that a rate is locked for its full term
- Both product pages linked from the homepage return 404, so the plan terms cannot be read before intake
Harper Meds
68/100Where the value is
- Genuinely all-inclusive pricing ('ONE PRICE for everything: doctor consultation, prescription, 4 weeks of medication & free shipping'), not a bare medication cost
- Flat pricing across all doses with no escalation as you titrate up
- Named operating entity (Nexus Health Solutions LLC) and named physician networks (Wasef Health, Beluga Health)
The tradeoffs
- State availability is not published on the pages read this session
- A LegitScript badge was not visible in the text I could confirm today — treat that certification claim as unverified until re-checked
Regulatory note: the FDA issued a warning letter to Nexus Health Solutions LLC dba Harper Meds in June 2026. We still list and link to Harper Meds; you should know the letter is on the public record before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.